Dr Daniel R Nussenzveig Md Dallas, TX - 75390

Dr Daniel R Nussenzveig Md is categorized under Doctors in Dallas, TX and active since 2011.

Dr Daniel R Nussenzveig Md was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Daniel R Nussenzveig Full Name Report at the company’s single location by writing to 5323 Harry Hines Boulevard, Dallas, Texas TX 75390 or by phoning (214) 645-6310 Full Phone Report. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dr Daniel R Nussenzveig Md
Contact Person: Daniel R Nussenzveig Full Name Report
Address: 5323 Harry Hines Boulevard, Dallas, Texas 75390
Phone Number: (214) 645-6310 Full Phone Report
Annual Revenue (USD): $100.000 to $499.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Dr Daniel R Nussenzveig Md was started in 2011 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Daniel R Nussenzveig Full Name Report for inquiries that concern Dr Daniel R Nussenzveig Md by calling the company number (214) 645-6310 Full Phone Report, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Daniel R Nussenzveig Md can be found at the coordinates 32.812648,-96.838721 as well as the street address 5323 Harry Hines Boulevard in Dallas, Texas 75390.

For its online presence, you may visit Dr Daniel R Nussenzveig Md’s website at and engage with its social media outlets through on Twitter and on Facebook.